Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)

NCT02287493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2021-12-14

Study results available
· View outcomes & findings →

Summary

In a prospective, non-interventional, monocentric observational study the pharmacokinetic properties of selected antiinfective drugs during sustained low-efficiency dialysis (SLED) will be analyzed.

Conditions

  • Replacement Therapy, Renal

Interventions

OTHER

Pharmacokinetic Analysis

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Stefan Kluge, Prof. Dr. · University Medical Center Hamburg-Eppendorf, Department of Intensive Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287493 on ClinicalTrials.gov